41.75↑-0.85 (-2.00%)
12:00 AM,1st Dec 2023BSE : 540788
NSE :
Sector : Health care
ISIN Code : INE500C01017
Last Updated: Dec 01 2023 | 12:00 AM IST
Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 0.00 |
All Time High Date | Invalid date |
All Time Low | 0.00 |
All Time Low Date | Invalid date |
Aspira Pathlab & Diagnostics Limited is a public limited company incorporated in July 03rd 1973. The Company is engaged into the business of running owning managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai.During the year the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of 'Ankur Pathology Laboratory'. The Company issued 2943000 equity shares of Rs. 10/- each at an issue price of Rs. 17/- per share (including share premium of Rs. 7/- per share) on preferential basis to promoters & group of strategic investors not forming part of the promoter. The allotment was made on 19th November 2016 & listing & trading approval is awaited. The paid-up capital as on 31st March 2017 was 5193000 equity shares of Rs. 10/- each.The Company has changed its object clause on 10th August 2016; its present name was changed on 16th November 2016 & registered office of the company was shifted from State of West Bengal to State of Maharashtra vide order dated 18th November 2016 & company again shifted its registered office within the city limit of Mumbai on 17th March 2017.During the year 2017 the Company applied to BSE Limited on 27th July 2017 under Direct Listing norms of BSE Limited for listing & trading of its securities at BSE Limited.During the year 2018-19 issued subscribed and paid- up capital of the of the Company has increased from 51930000 to Rs. 136930000/- divided into 8193000 Equity Shares of Rs. 10/- each and 5500000 9% Non-Cumulative Non-convertible Non-Participating Redeemable Preference Shares of Rs. 10/- each.The Company got delisting approval from Metropolitan Stock Exchange of India Limited and Calcutta Stock Exchange Limited w.e.f. April 12th 2018 and October 15th 2018 respectively.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 42 |
EPS - TTM (₹) [S] | 0.00 |
P/E Ratio (X) [S] | 3.80 |
Face Value (₹) | 10 |
Latest Dividend (%) | - |
Latest Dividend Date | - |
Dividend Yield (%) | - |
Book Value Share (₹) [S] | 11.00 |
P/B Ratio (₹) [S] | 3.80 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 41.75 42.00 |
Week Low/High | 39.90 44.00 |
Month Low/High | 34.30 44.00 |
Year Low/High | 22.76 50.00 |
All time Low/High | 14.15 124.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -0.33% | % | 2.29 | 2.39% |
1 Month | 12.05% | % | 6.12 | 6.73% |
3 Month | 3.39% | % | 3.20 | 4.28% |
6 Month | 34.63% | % | 8.09 | 9.63% |
1 Year | -2.34% | % | 6.63 | 7.74% |
3 Year | % | % | 51.12 | 54.61% |
Managing Director & CEO : Pankaj Jashwant Shah
Non Executive Director : Arvind Karsandas Bhanushali
Independent Director : Mangala Radha Krishnan Prabhu
Chairman : Haseeb Drabu
Director : Nikunj Mange
Independent Director : Subhash Raghunath Salunke
Independent Director : A C Mahajan
Registered Office: Flat No. 2 RD Shah Building, Shraddanand Road Ghatkopar(W),Mumbai,Maharashtra-400086 Ph: 91-22-71975756/5656